Scotland has become the UK leader in anti-cancer drug manufacturing with the opening of Cancer Research UK's £2 million drug-formulation unit at the University of Strathclyde. Scientists there will convert drug discoveries into forms that can be tested on patients, such as tablets or solutions for injection.